67-6

56/93

) De Marchi F, Araki M, Komatsu N: Molec-ular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia. Expert Rev Hematol. 2019; 12: 285- 293.) Shimizu T, Nakayama Y, Ishii E, Ida S, Satou T, Tokuhara D, Arai K, Nii M, Rydholm H, Yajima T: J-NEPECS (Japan Nexium Pediat-rics Study) Group: Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics. Pediatr Int. 2019; 61: 87-95.＊ 2) Shimizu Y, Yanobu-Takanashi R, Nakano K, Hamase K, Shimizu T, Okamura T: A dele-tion in the Ctns gene causes renal tubular dysfunction and cystine accumulation in LEA/Tohm rats. Mamm Genome. 2019; 30: 23-33.) Ohtomo Y: Bright light therapy as a non- pharmacological treatment for refractory enuresis. Pediatr Int. 2019; 61: 530.) Sakai-Bizmark R, Friedlander SMI, Oshima K, Webber EJ, Mena LA, Marr EH, Ohtsuka Y: Urban/rural residence effect on emer-gency department visits arising from food-in-duced anaphylaxis. Allergol Int. 2019; 68: 316-320.) Shinohara M, Ogawa S, Nakaya T, Niino R, Ito M, Haro K, Ishii E: Sex differences in the prevalence and severity of exercise-induced bronchoconstriction in kindergarteners in Japan. J Gen Fam Med. 2019; 20: 221-229.) Nambu R, Hagiwara SI, Kakuta F, Hara T, Shimizu H, Abukawa D, Iwama I, Kagimoto S, Arai K: Current role of colonoscopy in infants and young children: a multicenter study. BMC Gastroenterol. 2019; 19: 149.) Tajiri H, Arai K, Kagimoto S, Kunisaki R, Hida N, Sato N, Yamada H, Nagano M, Susuta Y, Ozaki K, Kondo K, Hibi T: Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan. BMC Pediatr. 2019; 19: 351.564Sato T, Takaku T, Shimono A, Takizawa H, Nakagata N, Mori S, Kurokawa M, Tenen D G, Osato M, Suda T, Komatsu N: Hlf marks the developmental pathway for hematopoi-etic stem cells but not for erythro-myeloid progenitors. J Exp Med. 2019; 216: 1599-1614. 15) Sugiyama M, Ueno Y, Kamo H, Edahiro Y, Miyamoto N, Yamashiro K, Tanaka R, Shimo Y, Komatsu N, Hattori N. Specific mecha-nisms of subarachnoid hemorrhage accompa-nied by ischemic stroke in essential thrombo-cythemia: two case reports and a literature review. J Neurol. 2019; 266: 1869-1878. 16) Araki M, Yang Y, Imai M, Mizukami Y, Kihara Y, Sunami Y, Masubuchi N, Edahiro Y, Hironaka Y, Osaga S, Ohsaka A, Komatsu N: Homomultimerization of mutant calretic-ulin is a prerequisite for MPL binding and activation. Leukemia. 2019; 33: 122-131. 17) Gerds A T, Tauchi T, Ritchie E, Deininger M, Jamieson C, Mesa R, Heaney M, Komatsu N, Minami H, Su Y, Shaik N, Zhang X, DiRienzo C, Zeremski M, Chan G, Talpaz M: Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib. Leuk Res. 2019; 79: 38-44. 18) Gerds A T, Tauchi T, Ritchie E, Deininger M, Jamieson C, Mesa R, Heaney M, Komatsu N, Minami H, Su Y, Shaik N, Zhang X, DiRienzo C, Zeremski M, Chan G, Talpaz M: Corri-gendum to “Phase 1/2 trial of glasdegib in patients with primary or secondary myelofi-brosis previously treated with ruxolitinib” [Leukemia Res. 79 (2019) 38-44]. Leuk Res 2019; 81: 10. 19) Ishikawa M, Iriyama N, Tokuhira M, Takaku T, Sato E, Sugimoto K-J, Nakazato T, Fujita H, Kimura Y, Fujioka I, Komatsu N, Asou N, Kizaki M, Hatta Y, Kawaguchi T: Potential role for second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromo-some abnormalities: A retrospective CML Cooperative Study Group analysis. Oncol Rep. 2019; 42: 2836-2843. 20) Kimura K, Tabe Y, Ai T, Takehara I, Fukuda H, Takahashi H, Naito T, Komatsu N, Uchi-hashi K, Ohsaka A: A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and AA. Sci Rep. 2019; 9: 13385.〈Reviews〉 1Pediatrics and Adolescent Medicine〈Original Articles〉 1 3 4 5 6 7